Hypercalcaemia in chronic lymphatic leukaemia (CLL) can be refractory to standard treatments. Osteoclast-stimulating factors may drive this severe complication, as evidenced by bone resorption.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: